TP53 and prostate carcinoma: Very recently, it was shown that R273C expressed in prostate cancer cells cannot independently bind to DNA and loses its transcriptional transactivation activity; however, modification of wild-type p53 results in enhanced colony formation, increases tumor cell survival after irradiation in vitro, and alters tumorigenic activity in vivo [48].